RankingsPricing
  1. US-listed companies
  2. REGENERON PHARMACEUTICALS, INC.
  3. Financials
  4. Operating margin (%)

REGENERON PHARMACEUTICALS, INC.REGN

Market cap
$81.6B
P/E ratio
SummaryFinancials
Period EndOperating margin (%) YoY (%)
Dec 31, 202428.1-8.93%
Dec 31, 202330.9-20.75%
Dec 31, 202238.9-30.07%
Dec 31, 202155.7+32.25%
Dec 31, 202042.1+49.78%
Dec 31, 201928.1-25.59%
Dec 31, 201837.8+6.64%
Dec 31, 201735.4+29.35%
Dec 31, 201627.4-10.25%
Dec 31, 201530.5+2.59%
Dec 31, 201429.7-17.65%
Dec 31, 201336.1+8.75%
Dec 31, 201233.2-172.16%
Dec 31, 2011-46+116.74%
Dec 31, 2010-21.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)